1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Amarin Neuroscience Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease Ethyl-EPA (Miraxion™) - Huntington Disease | Phase 3 | Completed | Amarin Neuroscience Ltd | 300 | 2005-09-01 | 2007-12-27 |
Huntington Disease (1) · Lymphoma, Follicular (1)
Docosahexaenoic Acids (1) · eicosapentaenoic acid ethyl ester (1)
Canada (1) · United States (1)
Blair Leavitt, MD (1) · Christopher Ross, MD, PhD (1) · Ira Shoulson, MD (1)